(PRWEB) October 20, 2016
HIFU Centers of America (HCOA) is world class prostate ablative and cancer curing organization. In more than 500 consecutive cases, safety is heralded, adverse events are minimized to absent and cure is maximized. In a comparison of HIFU (High Intensity Focused Ultrasound) experiences from around the USA and around the world with any HIFU technology, Ablatherm™ HIFU stands apart from every other organization.
The process includes excellence in patient selection utilizing the most sophisticated imaging available with a 3.0 Tesla Multi-parametric MRI scan. Our excellence in imaging and reading skill is equivalent to the best in the world. Additionally, virtually every procedure performed uses a patent pending innovation that has no equal. The unique ability to treat prostate tissue with acoustic energy (sound waves) using an enhanced energy application (EEA) has become the most promising standard by which HIFU will be judged presently and well into the future. For HIFU Centers of America the future is now.
At HCOA, failure to cure a cancer or adequately ablate prostate tissue has routinely become an historical footnote in time and uncommonly seen presently. Since 2013 men have been treated with Ablatherm™ HIFU in a single treatment session with an expected cure rate greater than 95%. In a concurrent consecutive case study (called the Sweet Spot Study), men with a PSA value of 8.5 ng/ml or less have achieved complete success with a biochemical disease free rate (BDFR) of virtually 100% with an absence of significant adverse events. Most impressive in our research and treatment protocol is the ability to predictably cure the most aggressive cancers that heretofore have required a secondary treatment and often times go on to chemotherapy. Prostate tissue ablation requires intense training and dedication on the part of every treating physician with only the most gifted physicians becoming a part of our team.
Most important to us all (as patients and physicians) is the end result or the outcome data. With upwards of 30% of patients or more failing an initial treatment associated with Cryosurgery, HIFU, Radiation or Radical Surgical removal (including the DaVinci Robot), it is incumbent on care providers to improve their performance dramatically or get on board with HIFU as a definitive treatment option for even the worst Gleason grades of cancer including Gleason scores of 7, 8, 9 or 10. Amazingly, we have taken patients with extraordinarily high PSA values (higher than 30.0 ng/ml in many instances) with an absence of extracapsular extension (ECE) as noted by the MP-MRI scan and provided cures for the majority. With our improved energy delivery protocol, men with aggressive disease (30-45% of all cancers diagnosed) noted at the time of biopsy and/or MRI scan get a new lease on life.
To learn more or if you have questions, contact us at: 1-877-766-8400 or visit us on line at: http://www.HIFUcoa.com.
We have enclosed a worldwide comparison of data (as an attachment) including results from the CaPSURE (community based) data set. Dr. Ronald Wheeler, an industry leader in the ablation of prostate tissue (HIFU) and in imaging with the highly sophisticated 3.0 Tesla MP-MRI scan will take your calls while answering your questions with an intent on making your health the best it can be from a prostate perspective.
HIFU Centers of America is a world leader in prostate diagnostics and treatment to the betterment of mankind!